Probiotics for Preventing Antibiotic-Associated Diarrhea in Children: An Updated Systematic Review

Authors

  • Clara Firhan Asifa Universitas Lampung, Indonesia Author
  • Huminsa Ranto MP RSUD KH Ahmad Hanafiah, Lampung, Indonesia Author
  • Farhan Dzaki Alfahri RSUD KH Ahmad Hanafiah, Lampung, Indonesia Author

Keywords:

probiotics, antibiotic-associated diarrhea, children, systematic review, randomized controlled trials

Abstract

Background: Antibiotic-associated diarrhea (AAD) is a common complication of systemic antibiotic therapy in children. Although probiotics are widely used for prevention, their effects vary across strains, formulations, treatment regimens, and clinical settings. This updated systematic review extends the established evidence base by incorporating randomized controlled trials published through July 2026 and evaluating efficacy and safety at the strain or formulation level.

Methods: The 33 randomized controlled trials included in the 2019 Cochrane review were used as the established evidence base. An updated search covering 29 May 2018 to 21 July 2026 identified eight additional eligible trials, resulting in 41 RCTs overall. Evidence was synthesized according to probiotic strain or formulation. Risk of bias was evaluated using RoB 2, and certainty of evidence was considered using GRADE principles.

Results: Probiotic effects were heterogeneous across strains, doses, antibiotic regimens, AAD definitions, and follow-up periods. Several preparations reduced AAD in specific populations, whereas others showed neutral or inconsistent effects. Findings for Limosilactobacillus reuteri DSM 17938 varied across trials, while newer studies of multispecies preparations, BB-12, and Bacillus strains further demonstrated context-dependent efficacy. Safety findings were generally reassuring, although rare adverse events could not be excluded.

Conclusion/Implications: Probiotics should not be considered a uniform therapeutic class for pediatric AAD. Clinical interpretation should be based on the specific strain or formulation, regimen, patient population, antibiotic exposure, and outcome definition. This strain- and context-specific approach provides a more appropriate basis for clinical decision-making and future pediatric probiotic research

References

Arvola, T., Laiho, K., Torkkeli, S., Mykkänen, H., Salminen, S., Maunula, L., & Isolauri, E. (1999). Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics, 104(5), e64. doi:10.1542/peds.104.5.e64.

Buffie, C. G., & Pamer, E. G. (2013). Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology, 13(11), 790–801. doi:10.1038/nri3535.

Chung, A. M., Sehgal, M., Gavrilita, C., Falkos, S., & Vidal, R. (2025). Lactobacillus GG in the prevention of antibiotic-associated diarrhea in the pediatric intensive care unit: A prospective randomized, double-blind placebo controlled intervention. Journal of Pediatric Pharmacology and Therapeutics, 30(1), 47–51. doi:10.5863/1551-6776-30.1.47.

Dinleyici, E. C., Ozen, M., Guven, S., Dalgic, N., Karbuz, A., Sutcu, M., Turel, O., Oz, F. N., Kirli, U., Yasar Durmus, S., Yazar, A. S., Cakin, Z. E., Vandenplas, Y., & Kara, A. (2025). Effect of Limosilactobacillus reuteri DSM17938 to prevent antibiotic-associated diarrhea in children: Prospective, multi-center, randomized, placebo-controlled clinical trial (PEARL Study). European Journal of Pediatrics, 184(7), Article 408. doi:10.1007/s00431-025-06249-8.

Fox, M. J., Ahuja, K. D. K., Robertson, I. K., Ball, M. J., & Eri, R. D. (2015). Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open, 5(1), e006474. doi:10.1136/bmjopen-2014-006474.

Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews, 2019(4), CD004827. doi:10.1002/14651858.CD004827.pub5.

Gün, E., Özdemir, H., Çelik, D. B., Botan, E., & Kendirli, T. (2022). Saccharomyces cerevisiae fungemia due to an unexpected source in the pediatric intensive care unit. The Turkish Journal of Pediatrics, 64(1), 138–141. doi:10.24953/turkjped.2020.1668.

Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008). GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924–926. doi:10.1136/bmj.39489.470347.AD.

Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Berni Canani, R., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. doi:10.1038/nrgastro.2014.66.

Kołodziej, M., & Szajewska, H. (2019). Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: A randomized clinical trial. Clinical Microbiology and Infection, 25(6), 699–704. doi:10.1016/j.cmi.2018.08.017.

Kotowska, M., Albrecht, P., & Szajewska, H. (2005). Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: A randomized double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics, 21(5), 583–590. doi:10.1111/j.1365-2036.2005.02356.x.

Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005). Lactobacillus sepsis associated with probiotic therapy. Pediatrics, 115(1), 178–181. doi:10.1542/peds.2004-2137.

Łukasik, J., Dierikx, T., Besseling-van der Vaart, I., de Meij, T., & Szajewska, H., on behalf of the Multispecies Probiotic in AAD Study Group. (2022). Multispecies probiotic for the prevention of antibiotic-associated diarrhea in children: A randomized clinical trial. JAMA Pediatrics, 176(9), 860–866. doi:10.1001/jamapediatrics.2022.1973.

McFarland, L. V. (2021). Efficacy of single-strain probiotics versus multi-strain mixtures: Systematic review of strain and disease specificity. Digestive Diseases and Sciences, 66(3), 694–704. doi:10.1007/s10620-020-06244-z.

McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018). Strain-specificity and disease-specificity of probiotic efficacy: A systematic review and meta-analysis. Frontiers in Medicine, 5, 124. doi:10.3389/fmed.2018.00124.

McFarland, L. V., Ozen, M., Dinleyici, E. C., & Goh, S. (2016). Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World Journal of Gastroenterology, 22(11), 3078–3104. doi:10.3748/wjg.v22.i11.3078.

Merenstein, D. J., Foster, J., & D'Amico, F. (2009). A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: The Measuring the Influence of Kefir (MILK) Study. Archives of Pediatrics & Adolescent Medicine, 163(8), 750–754. doi:10.1001/archpediatrics.2009.119.

Merenstein, D., Grant-Beurmann, S., Sanders, M. E., Tan, T., Burke, B., Kumar, A., Herbin-Smith, K., Sparenborg, J., D'Amico, F., Roberts, B., & Fraser, C. (2026). Probiotic intervention not beneficial to prevent antibiotic-associated diarrhea in absence of antibiotic-induced microbiome disruption. Scientific Reports, 16, Article 9301. doi:10.1038/s41598-026-39826-4.

Olek, A., Woynarowski, M., Ahrén, I. L., Kierkuś, J., Socha, P., Larsson, N., & Önning, G. (2017). Efficacy and safety of Lactobacillus plantarum DSM 9843 (LP299V) in the prevention of antibiotic-associated gastrointestinal symptoms in children: Randomized, double-blind, placebo-controlled study. The Journal of Pediatrics, 186, 82–86. doi:10.1016/j.jpeds.2017.03.047.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., . . . Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. doi:10.1136/bmj.n71.

Plaza-Díaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019). Mechanisms of action of probiotics. Advances in Nutrition, 10(Suppl. 1), S49–S66. doi:10.1093/advances/nmy063.

Shan, L.-S., Hou, P., Wang, Z.-J., Liu, F.-R., Chen, N., Shu, L.-H., Zhang, H., Han, X.-H., Han, X.-X., Cai, X.-X., Shang, Y.-X., & Vandenplas, Y. (2013). Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Beneficial Microbes, 4(4), 329–334. doi:10.3920/BM2013.0008.

Shashidhar, Anvesh, G., Soman, R. J., Soman, D., & Kishan, V. (2026). Evaluation of Bacillus clausii probiotic formulations in the prevention of antibiotic-associated diarrhea in infants and children: A randomized, double-blind, placebo-controlled study. International Journal of Probiotics & Prebiotics, 21(1). doi:10.37290/ijpp.v21i1.23.

Shyoran, R., Kaur, A., Bharat, P., & Pathania, R. (2024). Effect of probiotic yogurt on antibiotic-associated diarrhea among pediatric patients: Randomized controlled trial. Journal of Education and Health Promotion, 13, 317. doi:10.4103/jehp.jehp_1497_23.

Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernán, M. A., Hopewell, S., Hróbjartsson, A., Junqueira, D. R., Jüni, P., Kirkham, J. J., Lasserson, T., Li, T., . . . Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. doi:10.1136/bmj.l4898.

Szajewska, H., Berni Canani, R., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., van Goudoever, J. B., & Weizman, Z. (2016). Probiotics for the prevention of antibiotic-associated diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition, 62(3), 495–506. doi:10.1097/MPG.0000000000001081.

Szajewska, H., Berni Canani, R., Domellöf, M., Guarino, A., Hojsak, I., Indrio, F., Lo Vecchio, A., Mihatsch, W. A., Mosca, A., Orel, R., Salvatore, S., Shamir, R., van den Akker, C. H. P., van Goudoever, J. B., Vandenplas, Y., & Weizman, Z. (2023). Probiotics for the management of pediatric gastrointestinal disorders: Position paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. Journal of Pediatric Gastroenterology and Nutrition, 76(2), 232–247. doi:10.1097/MPG.0000000000003633.

Szajewska, H., Kołodziej, M., Zalewski, B. M., Dinleyici, E. C., & Łukasik, J. (2026). Systematic review: Limosilactobacillus reuteri DSM 17938 for preventing antibiotic-associated diarrhoea in children. Journal of Pediatric Gastroenterology and Nutrition, 82(3), 781–789. doi:10.1002/jpn3.70320.

Theriot, C. M., & Young, V. B. (2015). Interactions between the gastrointestinal microbiome and Clostridium difficile. Annual Review of Microbiology, 69, 445–461. doi:10.1146/annurev-micro-091014-104115.

Turck, D., Bernet, J.-P., Marx, J., Kempf, H., Giard, P., Walbaum, O., Lacombe, A., Rembert, F., Toursel, F., Bernasconi, P., Gottrand, F., McFarland, L. V., & Bloch, K. (2003). Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. Journal of Pediatric Gastroenterology and Nutrition, 37(1), 22–26. doi:10.1097/00005176-200307000-00004.

van den Akker, C. H. P., Embleton, N. D., Lapillonne, A., Mihatsch, W. A., Salvatore, S., Canani, R. B., Dinleyici, E. C., Domellöf, M., Guarino, A., Gutiérrez-Castrellón, P., Hojsak, I., Indrio, F., Mosca, A., Orel, R., van Goudoever, J. H. B., Weizman, Z., Mader, S., Zimmermann, L. J. I., Shamir, R., . . . Szajewska, H. (2024). Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI. Journal of Pediatric Gastroenterology and Nutrition, 78(6), 1403–1408. doi:10.1002/jpn3.12204.

Yang, Q., Hu, Z., Lei, Y., Li, X., Xu, C., Zhang, J., Liu, H., & Du, X. (2023). Overview of systematic reviews of probiotics in the prevention and treatment of antibiotic-associated diarrhea in children. Frontiers in Pharmacology, 14, 1153070. doi:10.3389/fphar.2023.1153070.

Zhang, B., Xu, Y.-Z., Deng, Z.-H., Chu, B., Jiang, L.-R., & Vandenplas, Y. (2015). The efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard Helicobacter pylori eradication treatment in children. Pediatric Gastroenterology, Hepatology & Nutrition, 18(1), 17–22. doi:10.5223/pghn.2015.18.1.17.

Zhang, S.-W., Zhi, X., Wang, M.-Y., & Shen, D.-L. (2024). A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants and young children. Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics], 26(10), 1108–1114. doi:10.7499/j.issn.1008-8830.2401129.

Zhou, Q., Dai, W., Bao, Y., Chen, J., Han, X., Liu, C., Hou, M., Yao, H., Hao, C., Li, S., & Zheng, Y. (2023). Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic-associated diarrhea: A double-blind, randomized controlled trial. Clinical and Translational Medicine, 13(4), e1184. doi:10.1002/ctm2.1184.

Downloads

Published

2025-12-28

How to Cite

Probiotics for Preventing Antibiotic-Associated Diarrhea in Children: An Updated Systematic Review. (2025). Berkala Kesehatan Klinik, 19(2), 59-72. https://journal.sardjitohospital.co.id/index.php/bkk/article/view/32